Newsroom All the latest news from the Pierre Fabre Group Page inner navigation PRESS RELEASES PRESS AREA NEWS PUBLICATIONS TWITTER Press releases Filter Year Year20242023202220212020 Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Écrit le Min Max Appliquer Press release Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories 1 March 2024 Press release Pierre Fabre Laboratories, committed to combating rare pediatric diseases via innovative therapies. 29 February 2024 Press release Pierre Fabre Laboratories and the EspeRare Foundation to be honored with the EURORDIS Company Award for Patient Engagement 2024, in their approach to co-developing a treatment for XLHED. 16 February 2024 Load more Presse area Are you a journalist? Find all the press releases of the Pierre Fabre group. Join us News Filter Year Year20242023202220212020 Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Tags (field_news_tags) - Any -#CRCawarenessInternational Men's Day#OurBreastJourneyANNUAL REPORTSustainable developmentCOLLECTION PIERRE FABREConsortiumDIGITALEADVESMOLettre OuverteLymphomaMedicalInnovationMedicalScienceLiaisonMelanomaMSLPink OctoberOncologyStudyEventsPierre Fabre FoundationInnovationNominationsPartnershipsAwardsStrategyTalents Écrit le Min Max Appliquer #CRCawareness Events BLUE MARCH - Colorectal Cancer Awareness Month 1 March 2024 Awards PIERRE FABRE CONFIRMED AS ONE OF THE WORLD’S BEST EMPLOYERS 13 October 2023 ANNUAL REPORT Strategy 2023 Annual Report: Taking care of you helps us advance 31 August 2023 Consortium Sustainable development THE GREEN IMPACT INDEX CONSORTIUM IS PLEASED TO ANNOUNCE THE PUBLICATION OF AFNOR SPEC 2215 BY AFNOR: 17 July 2023 Load more Publications 23 April 2019 Brochure Botanical Expertise Pierre Fabre Follow our live news Social media type (field_social_media_type) FacebookInstagramTwitterLinkedin Appliquer No post to display
Press release Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories 1 March 2024
Press release Pierre Fabre Laboratories, committed to combating rare pediatric diseases via innovative therapies. 29 February 2024
Press release Pierre Fabre Laboratories and the EspeRare Foundation to be honored with the EURORDIS Company Award for Patient Engagement 2024, in their approach to co-developing a treatment for XLHED. 16 February 2024
Consortium Sustainable development THE GREEN IMPACT INDEX CONSORTIUM IS PLEASED TO ANNOUNCE THE PUBLICATION OF AFNOR SPEC 2215 BY AFNOR: 17 July 2023
